Showing 1 - 10 results of 10 for search 'Noriyuki Enomoto', query time: 0.04s
Refine Results
-
1
Clinical significance of myeloperoxidase-anti-neutrophil cytoplasmic antibody in idiopathic interstitial pneumonias. by Hironao Hozumi, Yoshiyuki Oyama, Hideki Yasui, Yuzo Suzuki, Masato Kono, Masato Karayama, Kazuki Furuhashi, Noriyuki Enomoto, Tomoyuki Fujisawa, Naoki Inui, Yutaro Nakamura, Takafumi Suda
Published 2018-01-01Get full text
Article -
2
Integrin α8 is a useful cell surface marker of alveolar lipofibroblasts by Atsuki Fukada, Yasunori Enomoto, Ryo Horiguchi, Yoichiro Aoshima, Shiori Meguro, Hideya Kawasaki, Isao Kosugi, Tomoyuki Fujisawa, Noriyuki Enomoto, Naoki Inui, Takafumi Suda, Toshihide Iwashita
Published 2025-01-01Get full text
Article -
3
Changes in the characteristics and outcomes of COVID-19 patients from the early pandemic to the delta variant epidemic: a nationwide population-based study by Koichi Miyashita, Hironao Hozumi, Kazuki Furuhashi, Eiji Nakatani, Yusuke Inoue, Hideki Yasui, Masato Karayama, Yuzo Suzuki, Tomoyuki Fujisawa, Noriyuki Enomoto, Naoki Inui, Toshiyuki Ojima, Takafumi Suda
Published 2023-12-01Get full text
Article -
4
Utility of serum Aspergillus-galactomannan antigen to evaluate the risk of severe acute exacerbation in chronic obstructive pulmonary disease. by Katsuhiro Yoshimura, Yuzo Suzuki, Yusuke Inoue, Koji Nishimoto, Kazutaka Mori, Masato Karayama, Hironao Hozumi, Kazuki Furuhashi, Noriyuki Enomoto, Tomoyuki Fujisawa, Yutaro Nakamura, Naoki Inui, Koushi Yokomura, Shiro Imokawa, Takafumi Suda
Published 2018-01-01Get full text
Article -
5
3D-CT-derived lung volumes and mortality risk in patients with fibrotic hypersensitivity pneumonitis by Shusuke Yazawa, Yuzo Suzuki, Yuko Tanaka, Koshi Yokomura, Masato Kono, Dai Hashimoto, Atsuki Fukada, Yusuke Inoue, Hideki Yasui, Hironao Hozumi, Masato Karayama, Kazuki Furuhashi, Noriyuki Enomoto, Tomoyuki Fujisawa, Naoki Inui, Takafumi Suda
Published 2025-01-01Get full text
Article -
6
Pulmonary Hyalinizing Granuloma With Favourable and Longitudinal Treatment Response by Suguru Kojima, Noriyuki Enomoto, Keisuke Morikawa, Shogo Nakai, Shusuke Yazawa, Yasutaka Mochizuka, Atsuki Fukada, Yuko Tanaka, Yusuke Inoue, Hideki Yasui, Hironao Hozumi, Yuzo Suzuki, Masato Karayama, Kazuki Furuhashi, Tomoyuki Fujisawa, Naoki Inui, Takafumi Suda
Published 2025-04-01Get full text
Article -
7
Alveolar Sarcoidosis Mimicking Idiopathic Interstitial Pneumonia Without Mediastinal Lymphadenopathy by Hiroki Kanasaki, Noriyuki Enomoto, Yuko Tanaka, Suguru Kojima, Keisuke Morikawa, Shogo Nakai, Shusuke Yazawa, Yasutaka Mochizuka, Yusuke Inoue, Hideki Yasui, Hironao Hozumi, Yuzo Suzuki, Masato Karayama, Kazuki Furuhashi, Tomoyuki Fujisawa, Naoki Inui, Sayaka Ishigaki, Naro Ohashi, Yasunori Enomoto, Satoshi Baba, Kazuhiro Tabata, Takeshi Johkoh, Takafumi Suda
Published 2025-07-01Get full text
Article -
8
Lethal co-expression intolerance underlies the mutually exclusive expression of ASCL1 and NEUROD1 in SCLC cells by Hirofumi Watanabe, Yusuke Inoue, Kazuo Tsuchiya, Kazuhiro Asada, Makoto Suzuki, Hiroshi Ogawa, Masayuki Tanahashi, Takuya Watanabe, Shun Matsuura, Kazuyo Yasuda, Ippei Ohnishi, Shiro Imokawa, Hideki Yasui, Masato Karayama, Yuzo Suzuki, Hironao Hozumi, Kazuki Furuhashi, Noriyuki Enomoto, Tomoyuki Fujisawa, Kazuhito Funai, Kazuya Shinmura, Haruhiko Sugimura, Naoki Inui, Takafumi Suda
Published 2025-03-01Get full text
Article -
9
Analysis of the relationship between bronchoalveolar lavage lymphocyte fraction and detailed autoimmune features in patients with idiopathic interstitial pneumonia by Noriyuki Enomoto, Masayuki Watanuki, Shogo Nakai, Shusuke Yazawa, Yasutaka Mochizuka, Atsuki Fukada, Yuko Tanaka, Hyogo Naoi, Yusuke Inoue, Hideki Yasui, Masato Karayama, Yuzo Suzuki, Hironao Hozumi, Kazuki Furuhashi, Mikio Toyoshima, Masato Kono, Shiro Imokawa, Masato Fujii, Taisuke Akamatsu, Naoki Koshimizu, Koshi Yokomura, Hiroyuki Matsuda, Yusuke Kaida, Yutaro Nakamura, Masahiro Shirai, Kazutaka Mori, Masafumi Masuda, Tomoyuki Fujisawa, Naoki Inui, Hiroaki Sugiura, Hiromitsu Sumikawa, Masashi Kitani, Kazuhiro Tabata, Noriyoshi Ogawa, Takafumi Suda
Published 2025-07-01Get full text
Article -
10
Post-discontinuation Survival in Patients With Advanced NSCLC Receiving Immune Checkpoint Inhibitors: A Pooled Analysis of Prospective Cohort Studies by Yusuke Inoue, MD, PhD, Yoshihiro Kitahara, MD, Masato Karayama, MD, PhD, Kazuhiro Asada, MD, PhD, Koji Nishimoto, MD, PhD, Shun Matsuura, MD, PhD, Dai Hashimoto, MD, PhD, Masato Fujii, MD, PhD, Takashi Matsui, MD, PhD, Nao Inami, MD, Mikio Toyoshima, MD, PhD, Hiroyuki Matsuda, MD, PhD, Masaki Ikeda, MD, PhD, Mitsuru Niwa, MD, PhD, Yusuke Kaida, MD, PhD, Masaki Sato, MD, PhD, Yasuhiro Ito, MD, Hideki Yasui, MD, PhD, Yuzo Suzuki, MD, PhD, Hironao Hozumi, MD, PhD, Kazuki Furuhashi, MD, PhD, Noriyuki Enomoto, MD, PhD, Tomoyuki Fujisawa, MD, PhD, Naoki Inui, MD, PhD, Takafumi Suda, MD, PhD
Published 2025-08-01Get full text
Article